Algernon Pharmaceuticals (Algernon Pharmaceuticals) Dividend Payout Ratio : 0.00 (As of Feb. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Algernon Pharmaceuticals Dividend Payout Ratio?

Algernon Pharmaceuticals's dividend payout ratio for the months ended in Feb. 2024 was 0.00.

The historical rank and industry rank for Algernon Pharmaceuticals's Dividend Payout Ratio or its related term are showing as below:

AGNPF's Dividend Payout Ratio is not ranked ^*
in the Biotechnology industry.
Industry Median: 0.455
* Ranked among companies with meaningful Dividend Payout Ratio only.

As of today (2024-05-15), the Dividend Yield % of Algernon Pharmaceuticals is 0.00%.

Algernon Pharmaceuticals's Dividends per Share for the months ended in Feb. 2024 was $0.00.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.

Algernon Pharmaceuticals Dividend Payout Ratio Historical Data

The historical data trend for Algernon Pharmaceuticals's Dividend Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Algernon Pharmaceuticals Dividend Payout Ratio Chart

Algernon Pharmaceuticals Annual Data

Trend

Aug15

Aug16

Aug17

Aug18

Aug19

Aug20

Aug21

Aug22

Aug23

Dividend Payout Ratio

Get a 7-Day Free Trial

Algernon Pharmaceuticals Quarterly Data
	May19	Aug19	Nov19	Feb20	May20	Aug20	Nov20	Feb21	May21	Aug21	Nov21	Feb22	May22	Aug22	Nov22	Feb23	May23	Aug23	Nov23	Feb24
Dividend Payout Ratio	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Algernon Pharmaceuticals's Dividend Payout Ratio

For the Biotechnology subindustry, Algernon Pharmaceuticals's Dividend Payout Ratio, along with its competitors' market caps and Dividend Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Algernon Pharmaceuticals's Dividend Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Algernon Pharmaceuticals's Dividend Payout Ratio distribution charts can be found below:

* The bar in red indicates where Algernon Pharmaceuticals's Dividend Payout Ratio falls into.

Algernon Pharmaceuticals Dividend Payout Ratio Calculation

Dividend payout ratio measures the percentage of the company's earnings paid out as dividends.

Algernon Pharmaceuticals's Dividend Payout Ratio for the fiscal year that ended in Aug. 2023 is calculated as

Dividend Payout Ratio	=	Dividends per Share (A: Aug. 2023 )	/	EPS without NRI (A: Aug. 2023 )
	=	0	/	-0.258
	=	N/A

Algernon Pharmaceuticals's Dividend Payout Ratio for the quarter that ended in Feb. 2024 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Feb. 2024 )	/	EPS without NRI (Q: Feb. 2024 )
	=	0	/	-0.037
	=	N/A

Algernon Pharmaceuticals (OTCPK:AGNPF) Dividend Payout Ratio Explanation

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

Algernon Pharmaceuticals Dividend Payout Ratio Related Terms

Thank you for viewing the detailed overview of Algernon Pharmaceuticals's Dividend Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

Algernon Pharmaceuticals (Algernon Pharmaceuticals) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Algernon Pharmaceuticals Inc (OTCPK:AGNPF) » Definitions » Dividend Payout Ratio

Comparable Companies

Traded in Other Exchanges

AGW0:Germany AGN:Canada

Address

601 West Broadway, Suite 400, Vancouver, BC, CAN, V5Z 4C2

Website

https://www.algernonpharmaceuticals.com

Algernon Pharmaceuticals Inc is a clinical-stage drug development company focused on the disease areas of stroke, idiopathic pulmonary fibrosis and chronic cough. The company's business model is capital efficient and strives to deliver maximum shareholder value. Algernon's approach to drug discovery is based on the concept of drug repurposing. It operates in two reportable segments: the development of repurposed therapeutic drugs in Canada, and the facilitation of the Company's drug candidates into off-label phase II clinical trials (humans) in Australia.